Reaction

Hypophysitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,986 reports · 41 co-occurring drugs

As of the last recalculation, Hypophysitis appears in 1,986 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is IPILIMUMAB (PRR 566.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ipilimumab	1,074	566.7	581.2
Nivolumab	796	143.3	144.5
Pembrolizumab	471	61.2	61.5
Atezolizumab	146	42.4	42.6
Durvalumab	70	37.3	37.5
Pemetrexed	63	31.8	31.9
Pemetrexed Disodium	73	20.8	20.8
Carboplatin	196	17.8	17.9
Anti-Itch	97	15.9	15.9
Anti-Pruritic	97	15.9	15.9
Antipruritic (Anti-Itch)	97	15.9	15.9
Cool Relief Gel With Aloe	97	15.9	15.9
Drs. Hydrocortisone	97	15.9	15.9
Hydrocortisone Continuous Spray	97	15.9	15.9
Hydrocortisone Spray	97	15.9	15.9
Anti-Itch Cream	97	15.9	15.9
Hydrocortisone Lotion	97	15.9	15.9
Hydrocortisone Cream 1%	97	15.9	15.9
Hydrocortisone Cream 1/2%	97	15.9	15.9
Hydrocortisone 1%	97	15.9	15.9
Hydrocortisone Cream	97	15.8	15.8
Paclitaxel (Aibumin-Bound)	113	15.2	15.2
Vemurafenib	17	14.9	15.0
Hydrocortisone Acetate	97	14.7	14.7
Paclitaxel	125	14.0	14.1
Dabrafenib	27	13.6	13.6
Hydrocortisone	98	12.1	12.1
Trametinib	26	11.4	11.4
Hydrocortisone Sodium Succinate	10	11.2	11.2
Encorafenib	9	9.6	9.6
Gefitinib	8	9.3	9.3
Lenvatinib	25	8.1	8.1
Prochlorperazine Maleate	6	6.8	6.8
Bevacizumab	78	6.8	6.8
Axitinib	11	5.9	5.9
Etoposide	32	4.6	4.6
Cisplatin	32	4.3	4.3
Cabozantinib	19	4.2	4.2
Iohexol	3	3.8	3.8
Tapentadol Hydrochloride	7	2.2	2.2
Somatropin	13	1.9	1.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.